Curis | CRIS - Ordinary Share Capital


Curis reported $59K in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 59K 934K Sep/2023
Eli Lilly USD 946.83M 354.23M Jun/2025
Exelixis USD 268.1M 2.03M Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Verastem USD 4K 1000 Sep/2024
Xoma USD 87K 1000 Jun/2024